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A B S T R A C T
Certain anatomic and functional parameters of the eye change with increasing chronological age. They
may, therefore, serve as potential biomarkers of ageing. We investigated associations between four such
ocular parameters (lens density, retinal vessel calibre, corneal endothelial cells and retinal nerve fibre
layer thickness) and two ‘cellular’ biomarkers of ageing (leukocyte telomere length and CDKN2A
expression), with frailty (a clinical correlate of biological ageing) in a population of South African adults.
All ocular parameters revealed an association with either telomere length or CDKN2A expression.
However, lens density was most strongly correlated with age, increased CDKN2A expression, and with
frailty (p = 0.05 and 0.03, respectively). Narrow retinal arteriolar diameter, associated with increased
chronological age, was also associated with increased CDK2NA expression (0.42 vs. 0.31, p = 0.02) but not
with frailty. Ocular parameters may aid in determining biological age, warranting investigation in
longitudinal studies.
 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.
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There is substantial variation in the health and functional status
of older populations in many developing countries as well as in
developed countries (Lloyd-Sherlock et al., 2012). The reasons for
these variations are poorly understood, highlighting the need for
translational age-related research within a global context (Salomon
et al., 2013; Wang et al., 2013). Chronological age is an imprecise§ This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-No Derivative Works License, which
permits non-commercial use, distribution, and reproduction in any medium,
provided the original author and source are credited.
 Corresponding author at: International Centre for Eye Health, Department of
Clinical Research, LSHTM, Keppel Street, WC1E 7HT, UK. Tel.: +44 20 7958 8343;
fax: +44 20 7958 8325.
E-mail addresses: Sophia.pathai@lshtm.ac.uk, sophia.pathai@gmail.com
(S. Pathai).
0047-6374/$ – see front matter  2013 The Authors. Published by Elsevier Ireland Ltd
http://dx.doi.org/10.1016/j.mad.2013.05.002measure of biological ageing, due to inter-individual differences in
rates of ageing. The disconnection between chronological age and
lifespan has led to a search for effective and validated biomarkers of
ageing (BoA), defined as ‘‘biological parameters of an organism that
either alone or in some multivariate composite will better predict
functional capability at some late age, than will chronological age’’
(Baker and Sprott, 1988).
It is acknowledged that many age-related chronic diseases such
as cardiovascular disease and Alzheimer’s disease share common
pathways of early dysregulation, and that the development of
markers and diagnostic techniques is fundamental to understand-
ing healthy biological ageing and thus these diseases (Franco et al.,
2007). The need for research on how healthy ageing can be
achieved in the context of life-time trajectories has led to concept
of the ‘Healthy Ageing Phenotype’ (Franco et al., 2009). With
demonstrable molecular, epigenetic and clinical correlates of
ageing, the eye may be a model system for validating potential
biomarkers (Pathai et al., 2013b).. All rights reserved.
Table 1
Biomarkers of aging, methods of measurement and the impact of aging.
Anatomical site Parameter Method of measurement Age-related changes
Peripheral blood leukocytes Telomere length (TL) qPCR TL shortens
CDKN2A expression qRT-PCR to estimate mRNA levels Increased expression
Corneal endothelium Endothelial cell density (ECD) Specular microscopy Decreased ECD
Coefficient of variation (CV) Increased CV
Hexagonality index (Ex) Decreased Ex
Lens Lens opacity Pentacam – lens densitometry All increase
Linear value
Peak
3D average
Retina Retinal nerve fibre layer (RNFL)
thickness (average, superior,
inferior, nasal, temporal quadrants)
Optical coherence tomography (OCT) Thinner RNFL – all quadrants
Retinal vessel calibre Semi-automated retinal analysis software
applied to fundus photographs
Reduced diameter of arterioles
and arterio-venous ratio (AVR)
Systemic Frailty status Assessment of walking speed, grip strength,
self-report of weight loss, exhaustion
and low physical activity
Frailty status increases
Non-frail (no criteria)
Pre-frail (1–2 criteria)
Frail: 3 of 5 criteria
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visual functions permits investigation of a wide variety of
physiological and pathological mechanisms. Many age-related
ocular changes also have systemic associations or correlates of
ageing in other end-organs or body systems but may be easier and
less invasive to measure in the eye (Table 1). For example, changes
in the lens, which has an extremely high protein content, may
reflect systemic changes in protein structure and function in other
organs (Truscott, 2010, 2011; Wormstone and Wride, 2011).
Corneal endothelial cell parameters, lens density, retinal vessel
calibre and thickness of the retinal nerve fibre layer (RNFL) are
ocular parameters that vary with age that can be objectively and
non-invasively imaged and assessed.
Ideally, proposed ocular biomarkers should be assessed in
relation to established and validated BoA at a clinical or cellular
level. Only two validated BoA, telomere length (TL) and CDKN2A
expression, have so far been found to satisfy the majority of the
criteria proposed by Baker and Sprott (1988). Telomeres are
nucleoprotein complexes at the ends of eukaryotic chromosomes.
Their DNA component shortens with somatic cell division and
upon reaching a critically short length, a DNA damage signal leads
to growth cycle arrest, resulting in replicative senescence (Saretzki
and Von Zglinicki, 2002; von Zglinicki, 2002). Telomere shortening
is associated with increasing chronological age and several
pathologies, including cardiovascular disease (Starr et al., 2007)
and renal dysfunction (Carrero et al., 2008). TL may be useful as a
composite measure of healthy ageing, but not as a BoA when used
in isolation (Der et al., 2012; von Zglinicki, 2012). Expression levels
of the cell cycle regulator CDKN2A may represent a more robust
BoA (Shiels, 2010). CDKN2A acts as a tumour suppressor and
maintains cells in a state of growth arrest, both in replicative and
stress induced-senescence. Increasing levels of CDKN2A transcrip-
tional expression occur with increasing age and decreasing
function of solid organs and peripheral blood leucocytes (PBLs)
(Koppelstaetter et al., 2008; Krishnamurthy et al., 2004; Liu et al.,
2009; McGlynn et al., 2009). However, there are limited data on
how these parameters correlate with measures of physical frailty
(Woo et al., 2008), a functional state characterised by an increased
risk of multiple pathologies, low physical activity and slow motor
performance (Fried et al., 2001). Frailty predicts cognitive and
physical decline and is associated with an increased risk of
morbidity and mortality, and may therefore act as a ‘clinical’
biomarker of ageing (Fried et al., 2001).There are few data on biological ageing in sub-Saharan Africa, a
region where the population of elderly people is rapidly expanding,
and where the incidence of age-related non-communicable
diseases is steadily increasing (Marquez and Farrington, 2012).
The aim of this study was to investigate the association of a variety
of ocular candidate BoA with ‘systemic’ BoA and frailty status in a
South African adult population.
2. Methods
2.1. Study population
Individuals aged 30 years from an HIV prevention trials site in a township
community of Cape Town, South Africa (Emavundleni Centre, Crossroads) were
recruited as HIV-seronegative controls as part a case–control study investigating
HIV and ageing (Pathai et al., 2012, 2013a). Socio-demographic information and
medical history were obtained by interviewing participants in their first language
(Xhosa or English). Data collected included factors known to affect ageing (e.g. UV
exposure, smoking history). All participants underwent a full ophthalmic
examination including measurement of visual acuity, evaluation by slit lamp
microscopy and indirect ophthalmoscopy.
The study was approved by the Ethics Committees of the London School of
Hygiene and Tropical Medicine and the University of Cape Town Faculty of Health
Sciences, and adhered to the tenets of the Declaration of Helsinki. Written informed
consent was obtained from all participants.
2.2. Anthropometry, blood pressure and physical function including frailty assessment
Blood pressure (BP) was measured with a digital sphygmomanometer. Mean
arterial blood pressure (MABP) was defined as two-thirds of the diastolic plus one-
third of the systolic BP (Wong et al., 2003). Hypertension was defined as a systolic
BP of 140 mmHg or higher, diastolic BP of 90 mmHg or higher, or the combination of
self-reported high BP diagnosis and the use of anti-hypertensive medications
(Wong et al., 2005). Body mass index (BMI) was defined as weight (in kilograms)/
height2.
Physical frailty was defined by the presence of 3 of 5 criteria: (i) unintentional
weight loss (self reported and verified from clinic records where possible), (ii) self-
reported low physical activity, (iii) self-reported exhaustion, (iv) weak grip
strength and (v) slow walking time. Pre-frailty was defined as the presence of one
or two of these criteria. Detailed information is available in the Supplementary
Methods.
2.3. Blood-based biomarkers
2.3.1. DNA/RNA extraction
DNA was extracted from PBLs using the MaxwellTM Automated Purification
System according to manufacturer’s instructions (Promega, USA). DNA concentra-
tion and purity were quantified by Nanodrop Spectrophotometer (ThermoFisher
Scientific, USA). RNA was extracted using Trizol reagent (Invitrogen, UK) following
manufacturer’s guidelines. DNA/RNA extraction was performed in Cape Town and
samples shipped on dry ice to the University of Glasgow.
Table 2
Characteristics of study participants, n = 256.
Variable Male (N = 64)
N (%)
Female (N = 192)
N (%)
p
Age (mean  SE) 42.0  1.00 42.8  0.7 0.61
Median age, IQR 41 (35–48) 40 (35–49) 0.96
Age, years by group
30–39 27 (42.2) 91 (47.4)
40–49 28 (43.7) 56 (29.2)
>50 9 (14.1) 45 (23.4) 0.07
Education
Did not complete high school 15 (23.4) 32 (16.7)
Completed high school 49 (76.6) 160 (83.3) 0.23
Income
<ZAR1000/month 41 (64.1) 133 (69.3)
>ZAR1000/month 23 (35.9) 59 (30.7) 0.44
Location of work
Outdoors or grant-holder 44 (68.8) 140 (72.9)
Indoors 20 (31.2) 52 (27.1) 0.52
Housing
Formal 38 (59.4) 114 (59.4)
Informal 26 (40.6) 78 (40.6) 0.99
Shared WC
No 19 (29.7) 52 (27.1)
Yes 45 (70.3) 140 (72.9) 0.69
Number of people in household
Up to 5 40 (72.7) 125 (68.7)
6 15 (27.3) 57 (31.3) 0.57
Smoking status
Non-smoker 23 (35.9) 162 (83.4)
Smoker; <10 years 16 (25.0) 17 (8.9)
Smoker >10 years 25 (39.1) 13 (6.8) <0.0001
Alcohol
Nil 14 (21.9) 128 (66.7)
<1 L/week 14 (21.9) 43 (22.4)
>1 L/week 36 (56.2) 21 (10.9) <0.0001
Hypertension
No 36 (56.3) 141 (73.4)
Yes 28 (43.7) 51 (25.6) 0.01
BMI
<20 14 (21.9) 4 (2.1)
20–24.9 29 (45.3) 17 (8.9)
25.0–29.9 13 (20.3) 42 (21.9)
>30 8 (12.5) 129 (67.2) <0.0001
Tuberculosis status
No history 52 (81.3) 173 (90.1)
Previous history 12 (18.7) 18 (9.4)
Current 0 1 (0.5) 0.12
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Telomere lengths were determined by QPCR following the method of Cawthon
(Cawthon, 2002). Telomere length determination was performed blindly using a
Roche Light Cycler LC480. Briefly, telomere length analyses were performed in
triplicate for each sample, using a single-copy gene amplicon primer set (acidic
ribosomal phosphoprotein, 36B4) and a telomere-specific amplicon primer set
(Koppelstaetter et al., 2008). Refer to Supplementary Methods for further detail.
2.3.3. CDKN2A expression determination
Relative quantitative real-time PCR (qRT-PCR) was used to estimate mRNA levels
corresponding to the candidate senescence associated gene – CDKN2A. Expression
levels were measured against a reference hypoxanthine phosphoribosyltransferase
(HPRT) housekeeping gene on an ABI Prism(R) 7500 Sequence Detection System.
Sequences of human TaqManTM Primer/Probe sets were designed by Primer Express
algorithm (Applied Biosystems, Austin, TX, USA). The comparative threshold cycle
method (DDCT) (Livak and Schmittgen, 2001) was employed to quantify relative
gene expression.
2.4. Ocular biomarkers
The following four ocular parameters were selected (Table 1). Detailed methods
are supplied in the Supplementary Methods.
(i) Lens density: Pentacam imageing (Oculus, Wetzlar, Germany) was used to
obtain ‘‘Scheimpflug images’’ of the lens and to obtain an objective estimate of
lens density on a continuous scale. Lens density increases with increasing
chronological age.
(ii) Retinal vessel calibre: Participants had stereoscopic 30˚ colour retinal photo-
graphs taken under pharmacological pupil dilation with a fundus camera (CF-
2; Canon Inc., Tokyo, Japan). Vessel calibre indices were determined in a semi-
automated manner using the IVAN computer program (Singapore Eye Research
Institute, Singapore) and a standardized protocol described previously (Wong
et al., 2004). Narrowing of retinal arterioles is associated with increasing
chronological age (Leung et al., 2003; Wong et al., 2003).
(iii) Corneal endothelial cell parameters: A non-contact specular microscope was
used (SP02, CSO; Florence, Italy). The operator focused and aligned a real-time
image of the participant’s eye. Endothelial cell parameters were automatically
calculated from this image by the microscope software. Endothelial cell density
(ECD) decreases with age, whereas the change in cell size (coefficient of
variation) increases with age. The proportion of cells with six sides
(hexagonality index) decreases with age.
(iv) Retinal nerve fibre layer (RNFL): Measured using Spectral OCT/SLO optical
coherence tomography (Opko/OTI Inc, Miami, FL) which uses a scanning laser
diode of 830 nm to provide images of ocular microstructures. A peripapillary
(around optic nerve head) protocol inbuilt in the software was used to
determine the average and quadrant-specific RNFL thickness (superior,
inferior, temporal and nasal). The RNFL becomes thinner with increasing
age (Chi et al., 1995; Kanamori et al., 2003).
2.5. Statistical analysis
One eye was randomly selected for analysis. Where an eye was not available, for
example due to trauma or corneal opacity, the contralateral eye was used. Analyses
were performed using Stata 12 (Stata Corp., College Station, TX). Clinical and
biological data were summarized as the median with interquartile range (IQR) or
mean with standard error (SE), as appropriate. Analyses were conducted on log 10-
transformed values of telomere length and mean CDKN2A expression to satisfy the
assumption of normally distributed residuals. Results are displayed back-
transformed to the original scale. Validation of the biomarkers was performed
using linear regression models with age in years as a continuous or categorical
variable. Ocular biomarker measurements were divided into quartiles. Univariable
linear regression was performed to compare the quartiles of ocular parameters with
mean telomere length and CDKN2A expression and frailty status respectively.
Multivariable linear regression models were used to examine the relationships of
telomere length, CDKN2A expression as the respective dependent variable with
ocular biomarker quartiles and frailty status and explanatory variables (age group
[30–39; 40–49; >50 years], gender, MABP; BMI, smoking, UV exposure) as
independent variables. Marginal adjusted means for telomere length and CDKN2A
expression were estimated at the mean value of covariates in the model. The Wald
test was used to assess statistical significance of the association of each ocular
parameter on systemic biomarker levels.
3. Results
3.1. Participant characteristics and biomarker distributions
256 participants underwent assessment. Their median age was
40 years (IQR: 35–49) and 25% (n = 64) were male. Characteristicsof the participants by gender are given in Table 2. Women reported
less alcohol consumption and cigarette use than men (p < 0.0001
for both). Men had a higher frequency of hypertension and had
lower BMI (p = 0.01 and p < 0.0001, respectively). The number of
participants providing data for each parameter varied, as not every
participant was able to complete every ophthalmic test or had a
blood sample available for analysis. Summary statistics for each
biomarker, stratified by gender and age group are displayed in
Table S1. For the majority of biomarkers, there was no evidence of
gender differences; however for RNFL parameters, the average,
inferior and temporal quadrants were thinner in men (p = 0.01,
p = 0.0008 and p = 0.02, respectively).
3.2. Validation of blood-based and ocular biomarkers against
chronological age
Blood-based and ocular parameters were validated against
chronological age (Table S2). All parameters except retinal venular
S. Pathai et al. / Mechanisms of Ageing and Development 134 (2013) 338–345 341diameter and the RNFL nasal quadrant were related to chronologi-
cal age and so these parameters were not analysed further. The
association of telomere length, CDKN2A and linear lens density
with chronological age is presented Fig. 1a–c. The association of the
other prospective biomarkers is presented in Supplementary Fig.
1d–o. The R-squared values of the regressions against chronologi-
cal age were highest for lens density parameters (linear lens
density R2 = 0.67); other biomarkers including TL and CDKN2A had
R2 values <0.10. All analyses thereafter were adjusted for age,
gender and other possible confounding variables related to the
parameter of interest.Fig. 1. Scatter plots of biomarkers with chronological age. (a) Telomere length,
R2 = 0.02; (b) CDKN2A expression, R2 = 0.02; (c) linear lens density, R2 = 0.67.3.3. Association of ocular parameters with blood-based biomarkers
Shorter TL was associated with decreasing endothelial cell
density (p-trend = 0.08). CDKN2A expression was related to
increased variation in endothelial cell size in a non-linear fashion
(p = 0.05) (Table 3). The linear parameter of lens density was most
informative (Table 3). CDKN2A expression increased with in-
creased lens density (p-trend = 0.05); the 3-D average lens density
parameter also displayed a similar trend (p-trend = 0.08).
Expression of CDKN2A was associated with changes in the
calibre of retinal arterioles (p = 0.06) and in AVR (p = 0.03)
(Table 3), however a linear trend was not detected. When
arteriolar diameter was categorised as a binary variable, (‘thin’
or ‘thick’, i.e. either side of the median value) CDKN2A expression
was greater in those with thin compared to thick retinal arterioles
(0.42 vs. 0.31, p = 0.02). TL was not related to arteriolar diameter.
In view of the difference in RNFL thickness between genders
(Table S1), data were analysed for RNFL by gender. After
adjustment, there were no differences between genders (data
not shown), thus data for both men and women combined are
presented. Telomere length was informative for the superior
quadrant of the RNFL (Table S3), with shorter telomere length
associated with thinner RNFL (p-trend = 0.05).
3.4. Association of frailty status with blood-based and ocular
biomarkers
There was a significant trend of increased TL with worsening
frailty status (p-trend = 0.02) (Table 4). CDKN2A expression also
increased with frailty status, however this trend was not
statistically significant (p-trend = 0.12). Among the ocular bio-
markers, lens density was the only parameter associated with
frailty status, with increased linear lens density related to greater
frailty status (p-trend = 0.03).
4. Discussion
In this study we compared several ocular parameters with
established and validated systemic BoA (TL and CDKN2A expres-
sion) as well as frailty, a clinical correlate of ageing. Objective
measurement of lens density was the most informative ocular
biomarker, with greater lens density associated with increased
CDKN2A expression and with increased frailty status. Retinal
arteriolar narrowing was also associated with greater CDKN2A
expression. In contrast, lower endothelial cell density and thinning
of the RNFL were associated with shorter TL. These findings suggest
that a range of structural features of the eye, which can be
objectively imaged and measured, may reflect different physio-
logical parameters of ageing. These ocular BoA may provide
insights into biological age, ageing trajectories and a range of
chronic systemic diseases.
Lens density parameters had the strongest association with
chronological age compared to the other biomarkers and fulfil the
Baker and Sprott criteria (Baker and Sprott, 1988). Lens density was
the most informative ocular biomarker in that it was related to
CDKN2A expression, a cellular biomarker of ageing, as well as with
frailty status, a clinical correlate of systemic ageing. The human
lens is considered an ideal tissue for studying macromolecular
ageing, and physiological ageing in general, as biochemical
mechanisms in lens proteins may reflect ageing processes
elsewhere in the body (Eldred et al., 2011; Michael and Bron,
2011; Truscott, 2010, 2011; Truscott and Zhu, 2010; Wormstone
and Wride, 2011). Epidemiological research has demonstrated that
individuals with cataracts have a significantly higher mortality
rate than those without, even after adjusting for known
confounders (Wang et al., 2001; West et al., 2000). Crystallins
Table 3
Association of ocular parameters with blood-based biomarkers.
Endothelial cell parameters Telomere length CDKN2A expression
N Rel T/S p N Mean p
ECDa quartiles cells/mm2
1st (1952–2461) 59 1.06 (0.99–1.14) 47 0.42 (0.33–0.53)
2nd (2466–2612) 59 1.03 (0.96–1.10) 52 0.32 (0.25–0.40)
3rd (2617–2798) 58 1.10 (1.03–1.18) 54 0.36 (0.29–0.45)
4th (2812–3391) 60 1.14 (1.06–1.22) p-Trend 0.08 51 0.36 (0.29–0.46) 0.30
CVb quartiles
1st (26–32) 66 1.03 (0.97–1.10) 47 0.35 (0.28–0.38)
2nd (33–35) 70 1.08 (0.99–1.15) 52 0.31 (0.25–0.38)
3rd (36–38) 49 1.13 (1.04–1.22) 54 0.49 (0.38–0.64)
4th (39–57) 51 1.10 (1.02–1.19) 0.33 51 0.36 (0.28–0.46) 0.05
Exc quartiles
1st (24–46) 67 1.13 (1.06–1.20) 57 0.36 (0.29–0.45)
2nd (47–50) 59 1.05 (0.98–1.13) 61 0.40 (0.32–0.51)
3rd (51–54) 60 1.08 (1.00–1.15) 40 0.35 (0.28–0.44)
4th (55–70) 50 1.06 (0.98–1.14) 0.50 46 0.33 (0.25–0.42) 0.66
Lens densityd
Linear quartiles
1st (7.8–9.2) 62 1.01 (0.94–1.10) 51 0.29 (0.22–0.38)
2nd (9.25–9.8) 59 1.08 (1.00–1.17) 53 0.31 (0.24–0.40)
3rd (9.85–10.75) 58 1.14 (1.06–1.22) 50 0.37 (0.29–0.47)
4th (10.8–14.5) 61 1.09 (0.99–1.19) p-Trend 0.22 54 0.50 (0.37–0.68) p-Trend 0.05
Peak quartiles
1st (10.65–15.35) 61 0.93 (1.00–1.16) 57 0.36 (0.28–0.45)
2nd (15.4–18.0) 58 1.07 (1.00–1.15) 50 0.33 (0.26–0.41)
3rd (18.05–20.5) 61 1.10 (1.03–1.18) 51 0.37 (0.29–0.46)
4th (20.6–52.1) 60 1.07 (0.99–1.15) 0.92 50 0.39 (0.30–0.51) 0.81
3D-average quartiles
1st (8.3–9.1) 58 1.01 (0.92–1.09) 52 0.28 (0.21–0.37)
2nd (9.15–9.75) 64 1.08 (1.00–1.16) 54 0.39 (0.31–0.50)
3rd (9.8–10.85) 57 1.14 (1.06–1.23) 50 0.33 (0.26–0.43)
4th (10.9–19.7) 61 1.10 (1.00–1.20) p-Trend 0.16 52 0.46 (0.34–0.62) p-Trend 0.08
Retinal vessels
Retinal arteriolar quartiles (mm)
1st (102.62–150.30) 57 1.05 (0.98–1.13) 48 0.40 (0.31–0.51)
2nd (150.36–161.09) 59 1.13 (1.05–1.21) 50 0.43 (0.34–0.54)
3rd (161.35–172.72) 60 1.02 (0.95–1.09) 55 0.28 (0.22–0.35)
4th (172.74–209.71) 61 1.10 (1.03–1.19) 0.15 53 0.34 (0.27–0.44) 0.06
Endothelial parameters: adjusted for age, gender, smoking, UV exposure, income.
Lens density: adjusted for age, gender, smoking, UV exposure.
Vessels: adjusted for age, gender, smoking, BMI, hypertension and venular retinal calibre; 1st quartile denotes aged phenotype for all vessel parameters.
a Endothelial cell density –lowest quartile denotes aged phenotype.
b Coefficient of variation – i.e. difference in cell shape; highest quartile denotes aged phenotype.
c Hexagonality index – i.e. proportion of cells that are hexagonal; lowest quartile denotes aged phenotype.
d Measured on a continuous scale 0–100, 100 being an opaque (completely dense) lens; 4th quartile denotes aged phenotype for all lens parameters.
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responsible for the refractive power of the lens (Horwitz, 2000). In
other tissues crystallins are also involved in several cellular
pathways involving the stress response, apoptosis and cell survival
at a systemic and ocular level (Andley, 2008). Thus, crystallins are
not only involved in regulatory roles within the eye but also play
important roles in several other organs, leading to the suggestion
that cataract is a ‘bio-indicator’ for less obvious, more severe age-
related disorders (Graw, 2009). The concept of ‘lens transparency’
as a biomarker of ageing has already been described (Sanders et al.,
2011), and clinical diagnosis of cataract is associated with
leukocyte TL. However clinical cataract is generally diagnosed in
later years of life, whereas Scheimpflug imageing of lens density
provides objective measurements at any given age. Evaluation of
lens density across the age spectrum would be essential to evaluate
fully the usefulness of the lens as a biomarker of ageing, and testing
whether lens transparency is a predictor of mortality or longevity
would provide the strongest evidence. However, this approach
may be limited in well-resourced settings where surgical extrac-
tion of the lens often occurs with minimal lens opacities, renderingthe lens unavailable for assessment. However, lens density
measurement from early ages until lens extraction may still
provide insight into healthy ageing trajectories.
The retina represents a unique location where the microvascu-
lature can be directly and non-invasively visualised. The technique
of semi-automated software applied to digital retinal photographs
(Wong et al., 2004) is established as a valid and efficient biomarker
of systemic vascular disease (Ikram et al., 2006; Wong, 2006; Wong
et al., 2002). Retinal vascular calibre is considered a structural
marker of vascular pathology reflecting the interplay of systemic,
environmental and genetic factors (Sun et al., 2009). The strong
association between increasing age and narrowed retinal vessels
has been demonstrated in several study populations (Leung, 2003;
Wong, 2003). Small reductions in retinal arteriolar calibre are
associated with clinically relevant changes in blood pressure, e.g. a
10 mmHg increase in systolic BP is associated with a 1.1 mm
reduction in arteriolar calibre (Ikram et al., 2004). We found that
retinal arteriolar narrowing was associated with increased
CDKN2A expression, thus the retinal microvasculature reflect
senescent microvascular changes. However, retinal vessels can
Table 4
Association of frailty with systemic and ocular biomarkers of aging.
Biomarker Not-frail Pre-frail Frail p
Telomere length (N)
Rel T/S
89 127 34
1.01 (0.96–1.08) 1.09 (1.04–1.14) 1.17 (1.06–1.29) p-Trend 0.02
CDKN2A (N)
Mean expression
75 110 32
0.32 (0.26–0.39) 0.36 (0.31–0.42) 0.44 (0.32–0.60) p-Trend 0.12
Ocular parameter
Lens density (N)
Scale: 0–100
92 123 31 P
Linear 9.94 (9.77–10.13) 10.10 (9.94–10.25) 10.38 (10.05–10.71) p-Trend 0.03
Peak 18.82 (17.78–19.85) 18.68 (17.81–19.54) 18.86 (17.01–20.71) 0.97
3D-Average 10.02 (9.81–10.24) 10.14 (9.95–10.31) 10.31 (9.92–10.70) p-Trend 0.22
Vessel calibre (N) mm 92 120 31
CRAE 160.13 (156.56–163.70) 160.99 (157.97–164.01) 166.30 (159.87–172.72) p-Trend 0.19
AVR 0.60 (0.58–0.61) 0.60 (0.58–0.61) 0.61 (0.58–0.64) 0.64
Endothelial cell parameters (N) 91 121 31
ECDa cells/mm2 2637 (2580–2695) 2587 (2539–2635) 2675 (2572–2779) 0.18
CVb 35.1 (34.1–36.1) 35.3 (34.4–36.1) 36.9 (35.1–38.8) p-Trend 0.18
Exc 49.9 (48.6–51.3) 50.3 (49.1–51.4) 47.6 (42.3–50.0) 0.15
RNFL parameters (N) mm
Average 109.9 (106.7–113.2) 108.9 (105.6–110.6) 106.9 (101.4–112.4) p-Trend 0.31
Superior 131.1 (126.2–136.1) 133.4 (129.3–137.4) 130.6 (121.5–139.6) 0.73
Inferior 137.6 (132.6–142.6) 138.2 (134.1–142.3) 137.3 (127.2–146.5) 0.97
Temporal 72.3 (69.1–75.4) 72.6 (70.1–75.2) 72.2 (66.4–77.9) 0.98
Adjusted for age, gender, socio-economic status, smoking, alcohol consumption and TB status.
a Endothelial cell density – lowest quartile denotes aged phenotype.
b CV: coefficient of variation – i.e. difference in cell shape; highest quartile denotes aged phenotype.
c Hexagonality index – i.e. proportion of cells that are hexagonal; lowest quartile denotes aged phenotype.
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smoking and inflammatory diseases (Ikram et al., 2004; Klein et al.,
2006; Van Doornum et al., 2011) and may be manifest as a change
in retinal vessel calibre. This could affect the measurement of ‘true’
biological ageing, therefore the lens might be a better model and
biomarker of ageing as it is less susceptible to systemic pathology,
and therefore representing a true biomarker of ageing and not
disease (Simm et al., 2008).
Corneal endothelial cells change morphology and assume an
‘aged phenotype’ in several chronic systemic diseases (e.g. renal
failure, diabetes) (Larsson et al., 1996; Ohguro et al., 1999)
suggesting that they may be useful in assessing cellular dynamics
of ageing, particularly as measurement is objective and non-
invasive. Reduction in the proliferative capacity of corneal
endothelial cells is partly mediated by an age-related increase in
expression of CDKN2A that functions to hold a cell in a state of
growth arrest (Wang et al., 2012). Increased CDKN2A expression
was noted in those with the lowest endothelial cell density,
however this trend was not significant. In contrast, we found a
trend of decreasing endothelial cell density with shorter TL.
Evaluation of corneal endothelial cells via specular microscopy
may provide a unique way of measuring biological ageing at a
cellular level.
Thinning of the RNFL is associated with older age (Chi et al.,
1995; Kanamori et al., 2003), manifest functionally as deficits in
colour vision and contrast sensitivity. Our findings of thinner
superior RNFL associated with shorter TL are in alignment with
data from individuals with age-related neurocognitive disease.
Thinning of the superior RNFL in Alzheimer’s disease has been
observed (Lu et al., 2010; Paquet et al., 2007) and similar findings
have been noted in Parkinson’s disease and spinocerebellar ataxias
(Hajee et al., 2009; Pula et al., 2011). OCT measurement of the RNFL
is a quick non-invasive procedure, of importance for patients with
cognitive impairment. The retrograde loss of nerve fibre layer
tissue in the retina and optic nerve may be an early biomarker of
Alzheimer’s disease, and possibly the earliest sign of disease, prior
to damage to the hippocampal region that impacts memory(Valenti, 2011). Thus RNFL analysis may be best suited in detection
of early neurocognitive decline as a marker of ‘neurobiological
ageing’.
In relation to frailty and TL, a study (Woo et al., 2008) showed no
correlation between TL and frailty index. Indeed, women had
higher fraility scores and longer TLs. We also detected longer TL
with increasing frailty status which is not intuitive, as shorter
telomeres would be expected. One possible explanation for this, is
that induction of stress induced premature senescence (SIPS) (Shay
and Wright, 2000), leads to acute growth arrest (in contrast to
gradual replicative senescence). This may occur in frailty by a non-
quantified factor (e.g. genetics, environment, lifestyle) acting on
the affected cell population. Our finding that CDKN2A expression
does not follow a similar trend is supportive of such a hypothesis.
This would then be expected to result in longer TLs in cells under
SIPS contributing to frailty. An alternative explanation is a ‘survivor
effect’ i.e. individuals with poor biological ageing may die earlier,
thus participants comprise survivors who have different biological
characteristic to non-survivors, accounting for frail ‘survivors’
having longer telomeres. The relationship between the functional
phenotype of frailty (reflecting changes in multi-organ systems)
and cellular senescence represents two extremes of biological
ageing likely influenced by several external factors, thus a well-
defined relationship between these parameters maybe unlikely in
any case. Lens density was the only ocular parameter to be
associated with frailty, reinforcing its potential role as a biomarker
of ageing with associations with cellular BoA as well as the clinical
presentation of frailty.
This study has some limitations. Study participants were
matched by age, gender and socio-economic status to HIV-infected
individuals as part of a case–control study, and are not therefore
representative of the general population in South Africa. For
example, the gender composition of participants was three-
quarters female, reflective of the HIV epidemic in Africa, but not
representative of the South African population. There were also
differences between genders (smoking, alcohol consumption) that
may truly exist or may have been misclassified (e.g. misreporting
S. Pathai et al. / Mechanisms of Ageing and Development 134 (2013) 338–345344true smoking habits) and this could have confounded associations
of the ocular parameters with the other biomarkers. Participants
were recruited from a community of considerable socio-economic
depravation, and therefore likely to have been exposed to factors
known to increase biological ageing such as high UV exposure from
outdoor work. Therefore, our data might over-estimate associa-
tions related to ageing. Lastly, as study participants are of African
ancestry, our results are generalizable to the African population.
In conclusion, our study suggests that the eye has a useful and
valid contribution to make in the assessment of biological age. The
non-invasive and objective nature of the techniques is an added
benefit. Our data suggest that assessment of retinal vessel calibre
and lens density may be most informative. Further studies could
involve development of an ‘ocular ageing index’ using ocular
parameters to predict not only visual morbidity (visual im-
pairment/blindness), but also systemic morbidity and mortality.
RNFL parameters may be useful in developing an index for age-
related neurocognitive decline, whereas endothelial cell param-
eters may aid in understanding cellular mechanisms of senescence.
In resource-constrained settings access to facilities and personnel
capable of measuring biomarkers extracted from PBLs is likely to
be limited. Thus, ocular biomarkers in parallel with more easily
measurable systemic biomarkers (e.g. frailty status, blood counts)
to assess biological ageing may be more feasible in these
environments. Finally, we have proposed a research agenda to
further define and validate ocular biomarkers of ageing (Pathai
et al., 2013b). Longitudinal studies in different populations are
needed to assess how ocular parameters change over time in
relation to blood-based biomarkers and to other candidate
biomarkers that have been previously evaluated (Martin-Ruiz
et al., 2011; Simm et al., 2008). These parameters could also be
measured in longitudinal evaluation of the ‘healthy ageing
phenotype’ from early adult life onwards to characterise the
development of biological capital and ageing trajectories in terms
of a ‘life course’ approach (Kuh, 2007) leading to an improvement
in our understanding of how to achieve healthy ageing in societies
with rapidly increasing ageing populations.
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